156 related articles for article (PubMed ID: 27639957)
1. [Neuropsychological performance in neurofibromatosis type 1].
Hernández Del Castillo L; Martínez Bermejo A; Portellano Pérez JA; Tirado Requero P; Garriz Luis A; Velázquez Fragua R
An Pediatr (Barc); 2017 Aug; 87(2):73-77. PubMed ID: 27639957
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
3. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
Lorenzo J; Barton B; Arnold SS; North KN
J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
[TBL] [Abstract][Full Text] [Related]
4. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
Hyman SL; Shores A; North KN
Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
[TBL] [Abstract][Full Text] [Related]
5. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
Lidzba K; Granström S; Lindenau J; Mautner VF
Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
[TBL] [Abstract][Full Text] [Related]
6. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
[TBL] [Abstract][Full Text] [Related]
7. Detecting epilepsy-related cognitive problems in clinically referred children with epilepsy: is the WISC-IV a useful tool?
Sherman EM; Brooks BL; Fay-McClymont TB; MacAllister WS
Epilepsia; 2012 Jun; 53(6):1060-6. PubMed ID: 22554239
[TBL] [Abstract][Full Text] [Related]
8. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings.
Erdoğan-Bakar E; Cinbiş M; Ozyürek H; Kiriş N; Altunbaşak S; Anlar B
Turk J Pediatr; 2009; 51(6):565-71. PubMed ID: 20196390
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological evaluation and parental assessment of behavioral and motor difficulties in children with neurofibromatosis type 1.
Coutinho V; Kemlin I; Dorison N; Billette de Villemeur T; Rodriguez D; Dellatolas G
Res Dev Disabil; 2016 Jan; 48():220-30. PubMed ID: 26625207
[TBL] [Abstract][Full Text] [Related]
10. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
Payne JM; Arnold SS; Pride NA; North KN
Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
[TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
[TBL] [Abstract][Full Text] [Related]
12. Cognitive function and academic performance in children with neurofibromatosis type 1.
North K; Joy P; Yuille D; Cocks N; Hutchins P
Dev Med Child Neurol; 1995 May; 37(5):427-36. PubMed ID: 7768342
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
[TBL] [Abstract][Full Text] [Related]
14. Underlying mechanisms of writing difficulties among children with neurofibromatosis type 1.
Gilboa Y; Josman N; Fattal-Valevski A; Toledano-Alhadef H; Rosenblum S
Res Dev Disabil; 2014 Jun; 35(6):1310-6. PubMed ID: 24691356
[TBL] [Abstract][Full Text] [Related]
15. Motor impairment in children with Neurofibromatosis type 1: Effect of the comorbidity with language disorders.
Iannuzzi S; Albaret JM; Chignac C; Faure-Marie N; Barry I; Karsenty C; Chaix Y
Brain Dev; 2016 Feb; 38(2):181-7. PubMed ID: 26321374
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls.
Eldridge R; Denckla MB; Bien E; Myers S; Kaiser-Kupfer MI; Pikus A; Schlesinger SL; Parry DM; Dambrosia JM; Zasloff MA
Am J Dis Child; 1989 Jul; 143(7):833-7. PubMed ID: 2500844
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.
van der Vaart T; Rietman AB; Plasschaert E; Legius E; Elgersma Y; Moll HA;
Neurology; 2016 Jan; 86(2):154-60. PubMed ID: 26519538
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological deficits in adults with neurofibromatosis type 1.
Zöller ME; Rembeck B; Bäckman L
Acta Neurol Scand; 1997 Apr; 95(4):225-32. PubMed ID: 9150813
[TBL] [Abstract][Full Text] [Related]
20. Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas.
Hou Y; Allen T; Wolters PL; Toledo-Tamula MA; Martin S; Baldwin A; Reda S; Gillespie A; Goodwin A; Widemann BC
Dev Med Child Neurol; 2020 Aug; 62(8):977-984. PubMed ID: 32052421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
